$ARNA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARENA PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARENA PHARMACEUTICALS INC. Get notifications about new insider transactions in ARENA PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2012 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Option Exercise | A | 1.81 | 750,000 | 1,357,500 | 750,000 | |
Feb 07 2012 | ARNA | ARENA PHARMACEUTIC ... | Bielasz Jennifer Kathleen | Sr.Dir. of Acct. & ... | Buy | P | 1.90 | 30 | 57 | 30 | 0 to 30 |
Jan 10 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | J | 1.63 | 150 | 245 | 12,144 | 12.3 K to 12.1 K (-1.22 %) |
Jan 10 2012 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Buy | J | 1.64 | 150 | 246 | 12,294 | 12.1 K to 12.3 K (+1.24 %) |
Sep 15 2011 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 1.48 | 200,000 | 296,000 | 200,000 | |
Jun 14 2011 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Option Exercise | A | 1.27 | 36,000 | 45,720 | 36,000 | |
Jun 14 2011 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Option Exercise | A | 1.27 | 36,000 | 45,720 | 36,000 | |
Jun 14 2011 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | A | 1.27 | 36,000 | 45,720 | 36,000 | |
Jun 14 2011 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | A | 1.27 | 36,000 | 45,720 | 36,000 | |
Jun 14 2011 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Option Exercise | A | 1.27 | 36,000 | 45,720 | 36,000 | |
Jun 14 2011 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 1.27 | 36,000 | 45,720 | 36,000 | |
Jun 14 2011 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Option Exercise | A | 1.27 | 36,000 | 45,720 | 36,000 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | Bielasz Jennifer Kathleen | Sr. Dir. of Account ... | Option Exercise | A | 1.49 | 25,000 | 37,250 | 25,000 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Option Exercise | A | 1.49 | 52,268 | 77,879 | 52,268 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | AJIT-SIMH K A | Sr. VP, Quality & R ... | Option Exercise | A | 1.49 | 130,000 | 193,700 | 130,000 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Option Exercise | A | 1.49 | 22,067 | 32,880 | 22,067 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | A | 1.49 | 52,268 | 77,879 | 52,268 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | Sr. VP & Chief Medi ... | Option Exercise | A | 1.49 | 200,000 | 298,000 | 200,000 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | A | 1.49 | 52,268 | 77,879 | 52,268 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Option Exercise | A | 1.49 | 52,268 | 77,879 | 52,268 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 1.49 | 12,000 | 17,880 | 12,000 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Option Exercise | A | 1.49 | 52,268 | 77,879 | 52,268 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | Sr. VP, General Cou ... | Option Exercise | A | 1.49 | 300,000 | 447,000 | 300,000 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Option Exercise | A | 1.49 | 300,000 | 447,000 | 300,000 | |
Mar 17 2011 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Option Exercise | A | 1.49 | 300,000 | 447,000 | 300,000 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Option Exercise | A | 3.25 | 30,462 | 99,002 | 30,462 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 3.25 | 12,000 | 39,000 | 12,000 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | AJIT-SIMH K A | VP, Quality Systems | Option Exercise | A | 3.25 | 35,000 | 113,750 | 35,000 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Option Exercise | A | 3.25 | 16,615 | 53,999 | 16,615 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | A | 3.25 | 30,462 | 99,002 | 30,462 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | VP and Chief Medica ... | Option Exercise | A | 3.25 | 65,000 | 211,250 | 65,000 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | A | 3.25 | 30,462 | 99,002 | 30,462 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Option Exercise | A | 3.25 | 30,462 | 99,002 | 30,462 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Option Exercise | A | 3.25 | 30,462 | 99,002 | 30,462 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 3.25 | 100,000 | 325,000 | 100,000 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 3.25 | 65,000 | 211,250 | 65,000 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Option Exercise | A | 3.25 | 144,750 | 470,438 | 144,750 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Option Exercise | A | 3.25 | 100,000 | 325,000 | 100,000 | |
Mar 18 2010 | ARNA | ARENA PHARMACEUTIC ... | LAFORCE JAMES | Director | Option Exercise | A | 3.25 | 30,462 | 99,002 | 30,462 | |
Jan 28 2010 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Option Exercise | M | 0.60 | 27,500 | 16,500 | 0 | |
Jan 28 2010 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Buy | M | 0.60 | 27,500 | 16,500 | 423,000 | 395.5 K to 423 K (+6.95 %) |
May 14 2009 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Buy | P | 2.73 | 2,200 | 6,006 | 20,000 | 17.8 K to 20 K (+12.36 %) |
May 14 2009 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Buy | P | 2.73 | 7,800 | 21,286 | 17,800 | 10 K to 17.8 K (+78.00 %) |
May 14 2009 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Buy | P | 2.62 | 10,000 | 26,200 | 10,000 | 0 to 10 K |
May 14 2009 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Buy | P | 2.62 | 35,000 | 91,700 | 50,000 | 15 K to 50 K (+233.33 %) |
May 14 2009 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Buy | P | 2.67 | 3,800 | 10,146 | 4,900 | 1.1 K to 4.9 K (+345.45 %) |
May 14 2009 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Buy | P | 2.67 | 60,000 | 160,440 | 90,000 | 30 K to 90 K (+200.00 %) |
May 14 2009 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Buy | P | 2.75 | 1,000 | 2,750 | 1,000 | 0 to 1,000 |
May 14 2009 | ARNA | ARENA PHARMACEUTIC ... | LAFORCE JAMES | Director | Buy | P | 2.74 | 200 | 548 | 13,500 | 13.3 K to 13.5 K (+1.50 %) |
May 14 2009 | ARNA | ARENA PHARMACEUTIC ... | LAFORCE JAMES | Director | Buy | P | 2.74 | 3,300 | 9,040 | 13,300 | 10 K to 13.3 K (+33.00 %) |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Option Exercise | A | 4.01 | 26,963 | 108,122 | 26,963 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | AJIT-SIMH K A | VP, Quality Systems | Option Exercise | A | 4.01 | 20,000 | 80,200 | 20,000 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Option Exercise | A | 4.01 | 15,741 | 63,121 | 15,741 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | A | 4.01 | 26,963 | 108,122 | 26,963 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | VP and Chief Medica ... | Option Exercise | A | 4.01 | 40,000 | 160,400 | 40,000 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | A | 4.01 | 26,963 | 108,122 | 26,963 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Option Exercise | A | 4.01 | 26,963 | 108,122 | 26,963 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 4.01 | 12,000 | 48,120 | 12,000 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Option Exercise | A | 4.01 | 26,963 | 108,122 | 26,963 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 4.01 | 60,000 | 240,600 | 60,000 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 4.01 | 35,000 | 140,350 | 35,000 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | Chairman, President ... | Option Exercise | A | 4.01 | 180,000 | 721,800 | 180,000 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Option Exercise | A | 4.01 | 60,000 | 240,600 | 60,000 | |
Mar 18 2009 | ARNA | ARENA PHARMACEUTIC ... | LAFORCE JAMES | Director | Option Exercise | A | 4.01 | 26,963 | 108,122 | 26,963 | |
Feb 10 2009 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Option Exercise | M | 0.60 | 60,000 | 36,000 | 27,500 | |
Feb 10 2009 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Buy | M | 0.60 | 60,000 | 36,000 | 395,500 | 335.5 K to 395.5 K (+17.88 %) |
Sep 02 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 6.12 | 2,000 | 12,240 | 57,254 | 59.3 K to 57.3 K (-3.38 %) |
Sep 02 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 6.13 | 2,500 | 15,325 | 59,254 | 61.8 K to 59.3 K (-4.05 %) |
Sep 02 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 6.18 | 2,000 | 12,360 | 61,754 | 63.8 K to 61.8 K (-3.14 %) |
Sep 02 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 6.20 | 1,500 | 9,300 | 63,754 | 65.3 K to 63.8 K (-2.30 %) |
Sep 02 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 6.19 | 2,000 | 12,380 | 65,254 | 67.3 K to 65.3 K (-2.97 %) |
Aug 27 2008 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | President and CEO | Gift | G | 0.00 | 14,125 | 0 | 526,810 | 540.9 K to 526.8 K (-2.61 %) |
Jun 10 2008 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Buy | P | 4.69 | 20,000 | 93,740 | 30,000 | 10 K to 30 K (+200.00 %) |
May 13 2008 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Buy | P | 5.18 | 10,000 | 51,800 | 15,000 | 5 K to 15 K (+200.00 %) |
May 22 2008 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Buy | P | 5.05 | 4,000 | 20,200 | 10,000 | 6 K to 10 K (+66.67 %) |
May 22 2008 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Buy | P | 5.04 | 6,000 | 30,240 | 6,000 | 0 to 6 K |
May 13 2008 | ARNA | ARENA PHARMACEUTIC ... | LAFORCE JAMES | Director | Buy | P | 5.18 | 10,000 | 51,800 | 10,000 | 0 to 10 K |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Option Exercise | A | 6.99 | 20,584 | 143,882 | 20,584 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | AJIT-SIMH K A | VP, Quality Systems | Option Exercise | A | 6.99 | 20,000 | 139,800 | 20,000 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Option Exercise | A | 6.99 | 14,146 | 98,881 | 14,146 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | A | 6.99 | 9,584 | 66,992 | 9,584 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Option Exercise | A | 6.99 | 9,584 | 66,992 | 9,584 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | Nova Bennett Tina | Director | Option Exercise | A | 6.99 | 12,000 | 83,880 | 12,000 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | LAFORCE JAMES | Director | Option Exercise | A | 6.99 | 20,584 | 143,882 | 20,584 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Option Exercise | A | 6.99 | 20,584 | 143,882 | 20,584 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | VP, Chief Medical O ... | Option Exercise | A | 6.99 | 45,000 | 314,550 | 45,000 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | A | 6.99 | 20,584 | 143,882 | 20,584 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | SCOTTI LOUIS J | VP, Marketing and B ... | Option Exercise | A | 6.99 | 15,000 | 104,850 | 15,000 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 6.99 | 60,000 | 419,400 | 60,000 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 6.99 | 35,000 | 244,650 | 35,000 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | President and CEO | Option Exercise | A | 6.99 | 180,000 | 1,258,200 | 180,000 | |
Mar 05 2008 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Option Exercise | A | 6.99 | 60,000 | 419,400 | 60,000 | |
Feb 15 2008 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Gift | G | 0.00 | 700 | 0 | 66,544 | 67.2 K to 66.5 K (-1.04 %) |
Jan 16 2008 | ARNA | ARENA PHARMACEUTIC ... | WOODS RANDALL E | Director | Option Exercise | A | 8.29 | 18,000 | 149,220 | 18,000 | |
Jan 16 2008 | ARNA | ARENA PHARMACEUTIC ... | SCHNEIDER PHILLIP M | Director | Option Exercise | A | 8.29 | 18,000 | 149,220 | 18,000 | |
Dec 20 2007 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | President and CEO | Gift | G | 0.00 | 18,000 | 0 | 539,060 | 557.1 K to 539.1 K (-3.23 %) |
Dec 20 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Gift | G | 0.00 | 7,000 | 0 | 335,500 | 342.5 K to 335.5 K (-2.04 %) |
Oct 23 2007 | ARNA | ARENA PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 10.51 | 15,875 | 166,805 | 3,238,908 | 3.3 M to 3.2 M (-0.49 %) |
Oct 23 2007 | ARNA | ARENA PHARMACEUTIC ... | Flynn James E | 10% Owner | Sell | S | 10.51 | 9,125 | 95,880 | 1,861,735 | 1.9 M to 1.9 M (-0.49 %) |
Oct 02 2007 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Sell | S | 11.00 | 10,000 | 110,000 | 53,852 | 63.9 K to 53.9 K (-15.66 %) |
Sep 26 2007 | ARNA | ARENA PHARMACEUTIC ... | SCOTTI LOUIS J | VP, Marketing and B ... | Sell | S | 11.59 | 5,000 | 57,950 | 27,324 | 32.3 K to 27.3 K (-15.47 %) |
Jul 26 2007 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Gift | G | 0.00 | 1,200 | 0 | 67,039 | 68.2 K to 67 K (-1.76 %) |
Jun 15 2007 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | President and CEO | Gift | G | 0.00 | 7,000 | 0 | 555,810 | 562.8 K to 555.8 K (-1.24 %) |
Mar 20 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Option Exercise | M | 0.60 | 12,500 | 7,500 | 87,500 | |
Mar 20 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Option Exercise | M | 0.60 | 12,500 | 7,500 | 0 | |
Mar 20 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Buy | M | 0.60 | 12,500 | 7,500 | 342,500 | 330 K to 342.5 K (+3.79 %) |
Mar 20 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Buy | M | 0.60 | 12,500 | 7,500 | 330,000 | 317.5 K to 330 K (+3.94 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Option Exercise | M | 6.16 | 16,884 | 104,005 | 33,116 | |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Option Exercise | M | 6.00 | 16,668 | 100,008 | 33,332 | |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Sell | S | 11.26 | 3,000 | 33,780 | 317,500 | 320.5 K to 317.5 K (-0.94 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Sell | S | 11.24 | 3,000 | 33,720 | 320,500 | 323.5 K to 320.5 K (-0.93 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Sell | S | 11.23 | 6,000 | 67,380 | 323,500 | 329.5 K to 323.5 K (-1.82 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Sell | S | 11.22 | 7,905 | 88,694 | 329,500 | 337.4 K to 329.5 K (-2.34 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Sell | S | 11.21 | 5,000 | 56,050 | 337,405 | 342.4 K to 337.4 K (-1.46 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Sell | S | 11.20 | 13,500 | 151,200 | 342,405 | 355.9 K to 342.4 K (-3.79 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Sell | S | 11.19 | 6,052 | 67,722 | 355,905 | 362 K to 355.9 K (-1.67 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Sell | S | 11.17 | 4,595 | 51,326 | 361,957 | 366.6 K to 362 K (-1.25 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Sell | S | 11.16 | 7,905 | 88,220 | 366,552 | 374.5 K to 366.6 K (-2.11 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Sell | S | 11.15 | 1,595 | 17,784 | 374,457 | 376.1 K to 374.5 K (-0.42 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Buy | M | 6.16 | 16,884 | 104,005 | 376,052 | 359.2 K to 376.1 K (+4.70 %) |
Mar 16 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Buy | M | 6.00 | 16,668 | 100,008 | 359,168 | 342.5 K to 359.2 K (+4.87 %) |
Mar 15 2007 | ARNA | ARENA PHARMACEUTIC ... | SCOTTI LOUIS J | VP, Marketing and B ... | Sell | S | 11.32 | 2,800 | 31,696 | 31,757 | 34.6 K to 31.8 K (-8.10 %) |
Mar 15 2007 | ARNA | ARENA PHARMACEUTIC ... | SCOTTI LOUIS J | VP, Marketing and B ... | Sell | S | 11.33 | 2,200 | 24,926 | 34,557 | 36.8 K to 34.6 K (-5.99 %) |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Option Exercise | A | 13.50 | 16,444 | 221,994 | 16,444 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 13.50 | 12,000 | 162,000 | 12,000 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | AJIT-SIMH K A | VP, Quality Systems | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Option Exercise | A | 13.50 | 13,111 | 176,999 | 13,111 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | A | 13.50 | 16,444 | 221,994 | 16,444 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | SHANAHAN WILLIAM R JR | VP, Chief Medical O ... | Option Exercise | A | 13.50 | 45,000 | 607,500 | 45,000 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 13.50 | 60,000 | 810,000 | 60,000 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Option Exercise | A | 13.50 | 16,444 | 221,994 | 16,444 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | SCOTTI LOUIS J | VP, Marketing and B ... | Option Exercise | A | 13.50 | 15,000 | 202,500 | 15,000 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | A | 13.50 | 35,000 | 472,500 | 35,000 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | LIEF JACK | President and CEO | Option Exercise | A | 13.50 | 180,000 | 2,430,000 | 180,000 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | BEHAN DOMINIC P | SVP & Chief Scienti ... | Option Exercise | A | 13.50 | 60,000 | 810,000 | 60,000 | |
Feb 27 2007 | ARNA | ARENA PHARMACEUTIC ... | LAFORCE JAMES | Director | Option Exercise | A | 13.50 | 16,444 | 221,994 | 16,444 | |
Aug 14 2006 | ARNA | ARENA PHARMACEUTIC ... | White Christine Anna | Director | Option Exercise | A | 10.38 | 25,000 | 259,500 | 25,000 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | Nova Tina Susan | Director | Option Exercise | A | 10.52 | 10,000 | 105,200 | 10,000 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | HIXSON HARRY F JR | Director | Option Exercise | A | 10.52 | 15,703 | 165,196 | 15,703 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | BICE SCOTT H | Director | Option Exercise | A | 10.52 | 10,000 | 105,200 | 10,000 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | LAVIGNE LOUIS J JR | Director | Option Exercise | A | 10.52 | 10,000 | 105,200 | 10,000 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | LAFORCE JAMES | Director | Option Exercise | A | 10.52 | 15,703 | 165,196 | 15,703 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | BELCHER DONALD D | Director | Option Exercise | A | 10.52 | 15,703 | 165,196 | 15,703 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | SPECTOR STEVEN W | SVP, General Counse ... | Option Exercise | A | 10.52 | 10,000 | 105,200 | 10,000 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | SCOTTI LOUIS J | VP, Marketing and B ... | Option Exercise | A | 10.52 | 5,000 | 52,600 | 5,000 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | SCOTTI LOUIS J | VP, Marketing and B ... | Sell | S | 10.45 | 1,400 | 14,630 | 36,757 | 38.2 K to 36.8 K (-3.67 %) |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | SCOTTI LOUIS J | VP, Marketing and B ... | Sell | S | 10.37 | 400 | 4,148 | 38,157 | 38.6 K to 38.2 K (-1.04 %) |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | SCOTTI LOUIS J | VP, Marketing and B ... | Sell | S | 10.36 | 8,200 | 84,952 | 38,557 | 46.8 K to 38.6 K (-17.54 %) |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Option Exercise | M | 0.60 | 5,000 | 3,000 | 0 | |
Aug 01 2006 | ARNA | ARENA PHARMACEUTIC ... | HOFFMAN ROBERT | VP, Finance and CFO | Sell | S | 10.55 | 2,500 | 26,375 | 66,714 | 69.2 K to 66.7 K (-3.61 %) |